MARKET

WAT

WAT

Waters
NYSE
308.35
-1.90
-0.61%
After Hours: 308.30 -0.05 -0.02% 16:20 04/25 EDT
OPEN
309.28
PREV CLOSE
310.25
HIGH
310.20
LOW
303.87
VOLUME
381.56K
TURNOVER
0
52 WEEK HIGH
363.80
52 WEEK LOW
231.90
MARKET CAP
18.29B
P/E (TTM)
28.46
1D
5D
1M
3M
1Y
5Y
Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
The projected fair value for Waters Corporation is US$310 based on 2 Stage Free Cash Flow to Equity. Our fair value estimate is 4.8% lower than Waters' analyst price target of US$325. We use the Discounted Cash Flow model to estimate the intrinsic value of the company. The company is estimated to be worth US$18b. Waters' share price indicates it is trading at similar levels to its fair value.
Simply Wall St · 21h ago
Waters Reaches Analyst Target Price
NASDAQ · 1d ago
Tuesday Sector Leaders: Healthcare, Technology & Communications
NASDAQ · 2d ago
Danaher gains as Q1 results exceed expectations
Danaher (DHR) shares added ~9% premarket Tuesday after the company topped Street forecasts with its Q1 2024 financials. The life sciences toolmaker reported $5.8B in revenue for the quarter with a 3% YoY decline in sales.
Seeking Alpha · 2d ago
WATERS CORP <WAT.N>: BERNSTEIN CUTS TARGET PRICE TO $304 FROM $307
Reuters · 2d ago
WATERS ACCELERATES THE DEVELOPMENT OF GENE-BASED THERAPEUTICS WITH NEW GTXRESOLVE PREMIER SEC COLUMNS
Reuters · 3d ago
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics. Reduces problematic non-specific binding, minimizes mobile phase method development challenges, and provides higher throughput separation efficiency. Increases resolution up to 50% for components present within mRNA, lipid nanoparticles, and viral vectors.
PR Newswire · 3d ago
Weekly Report: what happened at WAT last week (0415-0419)?
Weekly Report · 3d ago
More
About WAT
Waters Corporation offers analytical instruments and software across chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments.

Webull offers Waters Corp stock information, including NYSE: WAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WAT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WAT stock methods without spending real money on the virtual paper trading platform.